Markus Riester
Markus Riester
Novartis Institutes for Biomedical Research
Verified email at
Cited by
Cited by
Specific effects of microRNAs on the plant transcriptome
R Schwab, JF Palatnik, M Riester, C Schommer, M Schmid, D Weigel
Developmental cell 8 (4), 517-527, 2005
Highly specific gene silencing by artificial microRNAs in Arabidopsis
R Schwab, S Ossowski, M Riester, N Warthmann, D Weigel
The Plant Cell 18 (5), 1121-1133, 2006
Most human non-GCIMP glioblastoma subtypes evolve from a common proneural-like precursor glioma
T Ozawa, M Riester, YK Cheng, JT Huse, M Squatrito, K Helmy, N Charles, ...
Cancer cell 26 (2), 288-300, 2014
Pharmacogenomic agreement between two cancer cell line data sets
Cancer Cell Line Encyclopedia Consortium, ...
Nature 528 (7580), 84, 2015
JAK–STAT pathway activation in malignant and nonmalignant cells contributes to MPN pathogenesis and therapeutic response
M Kleppe, M Kwak, P Koppikar, M Riester, M Keller, L Bastian, T Hricik, ...
Cancer discovery 5 (3), 316-331, 2015
Genetic mechanisms of target antigen loss in CAR19 therapy of acute lymphoblastic leukemia
EJ Orlando, X Han, C Tribouley, PA Wood, RJ Leary, M Riester, JE Levine, ...
Nature medicine 24 (10), 1504-1506, 2018
Risk Prediction for Late-Stage Ovarian Cancer by Meta-analysis of 1525 Patient Samples
M Riester, W Wei, L Waldron, AC Culhane, L Trippa, E Oliva, S Kim, ...
Journal of the National Cancer Institute, dju048, 2014
Combination of a novel gene expression signature with a clinical nomogram improves the prediction of survival in high-risk bladder cancer
M Riester, JM Taylor, A Feifer, T Koppie, JE Rosenberg, RJ Downey, ...
Clinical cancer research 18 (5), 1323-1333, 2012
curatedOvarianData: clinically annotated data for the ovarian cancer transcriptome
BF Ganzfried, M Riester, B Haibe-Kains, T Risch, S Tyekucheva, I Jazic, ...
Database 2013, 2013
Evolution of the cancer genome
O Podlaha, M Riester, S De, F Michor
Trends in Genetics 28 (4), 155-163, 2012
Molecular alterations and everolimus efficacy in human epidermal growth factor receptor 2–overexpressing metastatic breast cancers: combined exploratory biomarker analysis fromá…
F AndrÚ, S Hurvitz, A Fasolo, LM Tseng, G Jerusalem, S Wilks, R O’Regan, ...
Journal of Clinical Oncology 34 (18), 2115-2124, 2016
Aberration in DNA Methylation in B-Cell Lymphomas Has a Complex Origin and Increases with Disease Severity
S De, R Shaknovich, M Riester, O Elemento, H Geng, M Kormaksson, ...
PLoS genetics 9 (1), e1003137, 2013
FRANz: reconstruction of wild multi-generation pedigrees
M Riester, PF Stadler, K Klemm
Bioinformatics 25 (16), 2134-2139, 2009
Comparative meta-analysis of prognostic gene signatures for late-stage ovarian cancer
L Waldron, B Haibe-Kains, AC Culhane, M Riester, J Ding, XV Wang, ...
JNCI: Journal of the National Cancer Institute 106 (5), 2014
FGFR3 expression in primary and metastatic urothelial carcinoma of the bladder
EA Guancial, L Werner, J Bellmunt, A Bamias, TK Choueiri, R Ross, ...
Cancer medicine 3 (4), 835-844, 2014
Cross-study validation for the assessment of prediction algorithms
C Bernau, M Riester, AL Boulesteix, G Parmigiani, C Huttenhower, ...
Bioinformatics 30 (12), i105-i112, 2014
Tracking the evolution of resistance to ALK tyrosine kinase inhibitors through longitudinal analysis of circulating tumor DNA
I Dagogo-Jack, AR Brannon, LA Ferris, CD Campbell, JJ Lin, KR Schultz, ...
JCO precision oncology 2, 1-14, 2018
A differentiation-based phylogeny of cancer subtypes
M Riester, CSO Attolini, RJ Downey, S Singer, F Michor
PLoS Comput Biol 6 (5), e1000777, 2010
PureCN: copy number calling and SNV classification using targeted short read sequencing
M Riester, AP Singh, AR Brannon, K Yu, CD Campbell, DY Chiang, ...
Source code for biology and medicine 11 (1), 1-13, 2016
Software for the integration of multiomics experiments in Bioconductor
M Ramos, L Schiffer, A Re, R Azhar, A Basunia, C Rodriguez, T Chan, ...
Cancer research 77 (21), e39-e42, 2017
The system can't perform the operation now. Try again later.
Articles 1–20